AIA
TEVA icon

Affinity Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Affinity Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,923
Closed -$337K – 157
2025
Q1 		$337K Buy
21,923
+3,356
+18% +$59.9K 0.27% 102
2024
Q4 		$409K Buy
18,567
+2,376
+15% +$43.2K 0.34% 92
2024
Q3 		$292K Hold
16,191
– – 0.2% 114
2024
Q2 		$263K Sell
16,191
-8,626
-35% -$133K 0.2% 112
2024
Q1 		$350K Hold
24,817
– – 0.26% 101
2023
Q4 		$259K Buy
24,817
+636
+3% +$5.94K 0.18% 158
2023
Q3 		$247K Sell
24,181
-7,336
-23% -$68.3K 0.16% 169
2023
Q2 		$237K Buy
+31,517
New +$256K 0.14% 179

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Affinity Investment Advisors's TEVA Position: Q2 2025 in Review

Affinity Investment Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2025, closing a stake of 21,923 shares — an estimated $337K sold.

Affinity Investment Advisors first reported a position in TEVA in Q2 2023 and held it in 8 quarters. The position peaked at $409K in Q4 2024. 541 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • Affinity Investment Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2025 after selling out during the quarter.
  • Affinity Investment Advisors sold 21,923 Teva Pharmaceutical Industries Limited shares in Q2 2025, an estimated $337K.
  • Affinity Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2023 and held it in 8 quarters.
  • Affinity Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $409K in Q4 2024.
  • 541 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2025.

Based on Affinity Investment Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.